Finance
why BioXcel Therapeutics Inc [BTAI] is a Good Choice for Investors After New Price Target of $11.25
BioXcel Therapeutics Inc [NASDAQ: BTAI] jumped around 1.29 points on Friday, while shares priced at $3.75 at the close of the session, up 2.11%. The company report on February 8, 2024 at 4:01 PM that BioXcel Therapeutics Announces Proposed Public Offering. BofA Securities and Truist
